8-K Announcements
6Material company update
Mar 24, 2026·SEC
Material company update
Mar 6, 2026·SEC
Material company update
Jan 14, 2026·SEC
Absci Corporation(ABSI)Earnings, Financials & Key Ratios
ABSI•NASDAQ
$5.61
$872M mkt cap·Price updated May 6, 2026
AboutAbsci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.Show more
- Revenue$3M-38.2%
- EBITDA-$113M-18.3%
- Net Income-$115M-11.7%
- EPS (Diluted)-0.84+10.6%
- Gross Margin-319.36%+75.0%
- EBITDA Margin-4034.86%-91.6%
- Operating Margin-4454.21%-85.5%
- Net Margin-4113.68%-80.9%
- ROE-62.5%-7.7%
- ROIC-57.96%+5.0%
- Debt/Equity0.03-50.4%
- Interest Coverage-596.74-213.7%
ABSI Key Insights
Absci Corporation (ABSI) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Momentum leader: RS Rating 92 (top 8%)
- ✓Trading near 52-week high
✗Weaknesses
- ✗Profits declining 51.7% over 5 years
- ✗Negative free cash flow
- ✗Sales declining 10.1% over 5 years
- ✗Shares diluted 24.1% in last year
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
ABSI Price & Volume
Absci Corporation (ABSI) stock price & volume — 10-year historical chart
Loading chart...
ABSI Growth Metrics
Absci Corporation (ABSI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-10.14%
3 Years-21.31%
TTM-38.24%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-11.71%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM8.6%
Return on Capital
10 Years-43.31%
5 Years-47.17%
3 Years-57.54%
Last Year-65.9%
ABSI Recent Earnings
Absci Corporation (ABSI) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 1/12 qtrs (8%)●Beat Revenue 1/12 qtrs (8%)
Q2 2026Latest
Mar 24, 2026EPS
$0.23
Est $0.16
-43.8%
Revenue
$650,000
Est $1M
-54.2%
Q4 2025
Nov 12, 2025EPS
$0.20
Est $0.19
-5.3%
Revenue
$378,000
Est $1M
-72.6%
Q3 2025
Aug 12, 2025EPS
$0.24
Est $0.19
-26.3%
Revenue
$593,000
Est $5M
-88.5%
Q2 2025
May 13, 2025EPS
$0.21
Est $0.23
+8.7%
Revenue
$1M
Est $1M
-9.3%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 24, 2026 | $0.23vs $0.16-43.8% | $650,000vs $1M-54.2% |
| Q4 2025 | Nov 12, 2025 | $0.20vs $0.19-5.3% | $378,000vs $1M-72.6% |
| Q3 2025 | Aug 12, 2025 | $0.24vs $0.19-26.3% | $593,000vs $5M-88.5% |
| Q2 2025 | May 13, 2025 | $0.21vs $0.23+8.7% | $1Mvs $1M-9.3% |
Based on last 12 quarters of dataView full earnings history →
ABSI Peer Comparison
Absci Corporation (ABSI) competitors in Drug Discovery and Antibody Platforms — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 RXRX | 1.78B | 3.37 | -2.34 | 26.92% | -8.65% | -57.01% | 0.07 | |
 SDGR | 961.66M | 12.87 | -9.13 | 23.29% | -40.6% | -30.85% | 1.3% | 0.30 |
 ALIT | 466.51M | 0.89 | -0.15 | -3% | -137.5% | -171.72% | 53.59% | 1.92 |
 TWST | 3.48B | 56.70 | -43.62 | 20.32% | -19.85% | -17.46% | 0.29 | |
 BEAM | 2.97B | 28.90 | -35.68 | 120.01% | -57.24% | -7.31% | 0.24 | |
 NTLA | 1.55B | 13.31 | -3.49 | -100% | -61.47% | 0.14 | ||
 CRSP | 4.92B | 52.38 | -8.10 | -89.97% | -13.29% | -25.49% | 0.11 | |
 ILMN | 21.13B | 139.07 | 25.52 | -0.78% | 19.43% | 32.84% | 4.41% | 0.94 |
Compare ABSI vs Peers
Absci Corporation (ABSI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ABSI Income Statement
Absci Corporation (ABSI) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|
| Sales/Revenue | 2.06M | 4.78M | 4.78M | 5.75M | 5.72M | 4.53M | 2.8M |
| Revenue Growth % | - | 132.04% | 0.04% | 20.18% | -0.5% | -20.71% | -38.24% |
| Cost of Goods Sold | 0 | 11.45M | 44.59M | 58.91M | 47.57M | 62.46M | 11.74M |
| COGS % of Revenue | - | 239.5% | 932.37% | 1025.02% | 831.88% | 1377.57% | 419.36% |
| Gross Profit | 2.06M▲ 0% | -6.67M▼ 423.7% | -39.8M▼ 496.9% | -53.16M▼ 33.6% | -41.85M▲ 21.3% | -57.92M▼ 38.4% | -8.94M▲ 84.6% |
| Gross Margin % | 100% | -139.5% | -832.37% | -925.02% | -731.88% | -1277.57% | -319.36% |
| Gross Profit Growth % | - | -423.69% | -496.94% | -33.56% | 21.28% | -38.41% | 84.56% |
| Operating Expenses | 8.32M | 6.63M | 35.43M | 53.59M | 73.67M | 50.96M | 115.78M |
| OpEx % of Revenue | 404.13% | 138.77% | 740.99% | 932.47% | 1288.32% | 1124.02% | 4134.86% |
| Selling, General & Admin | 3.52M | 5.5M | 0 | 0 | 0 | 0 | 35.06M |
| SG&A % of Revenue | 171.02% | 115.1% | - | - | - | - | 1252.07% |
| Research & Development | 4.31M | 11.45M | 44.59M | 58.91M | 48.07M | 63.86M | 81.42M |
| R&D % of Revenue | 209.27% | 239.5% | 932.37% | 1025.02% | 840.63% | 1408.45% | 2907.79% |
| Other Operating Expenses | 491K | -10.32M | -9.15M | -5.32M | 25.6M | -12.9M | -700K |
| Operating Income | -6.26M▲ 0% | -13.3M▼ 112.3% | -75.24M▼ 465.7% | -106.75M▼ 41.9% | -115.52M▼ 8.2% | -108.89M▲ 5.7% | -124.72M▼ 14.5% |
| Operating Margin % | -304.13% | -278.26% | -1573.36% | -1857.49% | -2020.2% | -2401.59% | -4454.21% |
| Operating Income Growth % | - | -112.31% | -465.66% | -41.88% | -8.21% | 5.74% | -14.54% |
| EBITDA | -5.77M | -12.17M | -68.58M | -93.71M | -101.52M | -95.5M | -112.98M |
| EBITDA Margin % | -280.29% | -254.6% | -1434.21% | -1630.64% | -1775.38% | -2106.29% | -4034.86% |
| EBITDA Growth % | - | -110.77% | -463.55% | -36.64% | -8.33% | 5.93% | -18.3% |
| D&A (Non-Cash Add-back) | 491K | 1.13M | 6.65M | 13.04M | 14M | 13.39M | 11.74M |
| EBIT | -6.32M | -13.72M | -74.34M | -106.75M | -93.68M | -107.49M | -124.72M |
| Net Interest Income | -268K | -634K | -3.43M | -972K | -1.01M | -565K | -209K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 268K | 634K | 3.43M | 972K | 1.01M | 565K | 209K |
| Other Income/Expense | -319K | -1.05M | -34.62M | 1.39M | 5.05M | 5.85M | 9.6M |
| Pretax Income | -6.58M▲ 0% | -14.35M▼ 118.0% | -109.86M▼ 665.4% | -105.36M▲ 4.1% | -110.47M▼ 4.8% | -103.04M▲ 6.7% | -115.11M▼ 11.7% |
| Pretax Margin % | -319.61% | -300.27% | -2297.34% | -1833.39% | -1931.9% | -2272.52% | -4111.21% |
| Income Tax | 0 | 0 | -8.9M | -461K | 100K | 70K | 69K |
| Effective Tax Rate % | 0% | 0% | 8.1% | 0.44% | -0.09% | -0.07% | -0.06% |
| Net Income | -6.58M▲ 0% | -14.35M▼ 118.0% | -100.96M▼ 603.4% | -104.9M▼ 3.9% | -110.57M▼ 5.4% | -103.11M▲ 6.7% | -115.18M▼ 11.7% |
| Net Margin % | -319.61% | -300.27% | -2111.25% | -1825.37% | -1933.65% | -2274.06% | -4113.68% |
| Net Income Growth % | - | -118% | -603.41% | -3.91% | -5.4% | 6.75% | -11.71% |
| Net Income (Continuing) | -6.58M | -14.35M | -100.96M | -104.9M | -110.57M | -103.11M | -115.18M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.07▲ 0% | -0.54▼ 632.7% | -1.11▼ 105.6% | -1.15▼ 3.6% | -1.20▼ 4.3% | -0.94▲ 21.7% | -0.84▲ 10.6% |
| EPS Growth % | - | -632.7% | -105.56% | -3.6% | -4.35% | 21.67% | 10.64% |
| EPS (Basic) | -0.07 | -0.54 | -1.11 | -1.15 | -1.20 | -0.94 | -0.84 |
| Diluted Shares Outstanding | 92.25M | 92.25M | 92.65M | 90.85M | 92.03M | 110.24M | 136.78M |
| Basic Shares Outstanding | 92.25M | 92.25M | 92.65M | 90.85M | 92.03M | 110.24M | 136.78M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
ABSI Balance Sheet
Absci Corporation (ABSI) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 13.65M | 73.23M | 273.08M | 186.86M | 120.58M | 133.83M | 149.57M |
| Cash & Short-Term Investments | 13.09M | 69.87M | 252.57M | 164.43M | 97.66M | 112.42M | 144.29M |
| Cash Only | 13.09M | 69.87M | 252.57M | 59.95M | 72.36M | 41.21M | 20.02M |
| Short-Term Investments | 0 | 0 | 0 | 104.48M | 25.3M | 71.21M | 124.27M |
| Accounts Receivable | 222K | 1.59M | 1.43M | 1.55M | 2.19M | 0 | 0 |
| Days Sales Outstanding | 39.34 | 121.72 | 108.77 | 98.44 | 139.73 | - | - |
| Inventory | 0 | 0 | 10.51M | 15.02M | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | 86.06 | 93.08 | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 0 | 20.73M | 21.41M | 5.28M |
| Total Non-Current Assets | 5.82M | 15.34M | 153.12M | 134.15M | 96.72M | 79.78M | 66.72M |
| Property, Plant & Equipment | 5.01M | 13.38M | 58.65M | 58.04M | 45.82M | 33.13M | 23.77M |
| Fixed Asset Turnover | 0.41x | 0.36x | 0.08x | 0.10x | 0.12x | 0.14x | 0.12x |
| Goodwill | 0 | 0 | 21.34M | 21.34M | 0 | 0 | 0 |
| Intangible Assets | 283K | 0 | 54.99M | 51.62M | 48.25M | 44.88M | 41.51M |
| Long-Term Investments | 790K | 0 | 16.84M | 1.86M | 0 | 0 | 0 |
| Other Non-Current Assets | 531K | 1.95M | 18.14M | -16.38M | 2.65M | 1.76M | 1.44M |
| Total Assets | 19.47M▲ 0% | 88.57M▲ 354.9% | 426.19M▲ 381.2% | 321.01M▼ 24.7% | 217.3M▼ 32.3% | 213.61M▼ 1.7% | 216.3M▲ 1.3% |
| Asset Turnover | 0.11x | 0.05x | 0.01x | 0.02x | 0.03x | 0.02x | 0.01x |
| Asset Growth % | - | 354.88% | 381.2% | -24.68% | -32.31% | -1.7% | 1.26% |
| Total Current Liabilities | 3.47M | 10.1M | 33.86M | 30.27M | 29.56M | 28.66M | 22.77M |
| Accounts Payable | 268K | 2.12M | 8.38M | 2.41M | 1.5M | 3.53M | 2.76M |
| Days Payables Outstanding | - | 67.47 | 68.64 | 14.95 | 11.53 | 20.62 | 85.67 |
| Short-Term Debt | 1.2M | 1.53M | 2.4M | 2.95M | 3.26M | 2.73M | 873K |
| Deferred Revenue (Current) | 780K | 0 | 1.35M | 445K | 3.17M | 1.12M | 739K |
| Other Current Liabilities | 0 | 2.63M | 0 | 0 | 12.75M | 12.75M | 0 |
| Current Ratio | 3.94x | 7.25x | 8.07x | 6.17x | 4.08x | 4.67x | 6.57x |
| Quick Ratio | 3.94x | 7.25x | 7.75x | 5.68x | 4.08x | 4.67x | 6.57x |
| Cash Conversion Cycle | - | - | 126.19 | 176.58 | - | - | - |
| Total Non-Current Liabilities | 57.16M | 11.47M | 26.23M | 16.32M | 11.56M | 5.82M | 4.08M |
| Long-Term Debt | 1.75M | 4.14M | 1.12M | 7.98M | 4.66M | 1.26M | 3.5M |
| Capital Lease Obligations | 2.38M | 6.58M | 12.2M | 8.07M | 5.64M | 4.43M | 2.62M |
| Deferred Tax Liabilities | 0 | 0 | 743K | 238K | 186K | 0 | 0 |
| Other Non-Current Liabilities | 53.03M | 749K | 12.16M | 35K | 109K | 133K | 1.02M |
| Total Liabilities | 60.63M | 21.56M | 60.09M | 46.59M | 41.12M | 34.48M | 26.85M |
| Total Debt | 6.02M | 14.5M | 20.01M | 22.98M | 15.88M | 10.11M | 5.3M |
| Net Debt | -7.07M | -55.37M | -232.56M | -36.97M | -56.48M | -31.11M | -14.72M |
| Debt / Equity | - | 0.22x | 0.05x | 0.08x | 0.09x | 0.06x | 0.03x |
| Debt / EBITDA | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - |
| Interest Coverage | -23.57x | -21.64x | -21.66x | -109.83x | -92.75x | -190.24x | -596.74x |
| Total Equity | -41.16M▲ 0% | 67M▲ 262.8% | 366.11M▲ 446.4% | 274.41M▼ 25.0% | 176.18M▼ 35.8% | 179.13M▲ 1.7% | 189.45M▲ 5.8% |
| Equity Growth % | - | 262.8% | 446.39% | -25.05% | -35.8% | 1.68% | 5.76% |
| Book Value per Share | -0.45 | 0.73 | 3.95 | 3.02 | 1.91 | 1.62 | 1.39 |
| Total Shareholders' Equity | -41.16M | 67M | 366.11M | 274.41M | 176.18M | 179.13M | 189.45M |
| Common Stock | 2K | 2K | 9K | 9K | 9K | 12K | 15K |
| Retained Earnings | -41.38M | -90.06M | -191.03M | -295.93M | -406.5M | -509.6M | -624.78M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -52.76M | 0 | -13K | -120K | -37K | -4K | 591K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ABSI Cash Flow Statement
Absci Corporation (ABSI) cash flow — operating, investing & free cash flow history
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|
| Cash from Operations | -6.03M | -10.97M | -60.6M | -81.34M | -64.64M | -72.4M | -92.92M |
| Operating CF Margin % | -292.82% | -229.5% | -1267.21% | -1415.33% | -1130.4% | -1596.87% | -3318.75% |
| Operating CF Growth % | - | -81.86% | -452.4% | -34.23% | 20.54% | -12.02% | -28.35% |
| Net Income | -6.58M | -14.35M | -100.96M | -104.9M | -110.57M | -103.11M | -115.18M |
| Depreciation & Amortization | 491K | 1.13M | 6.65M | 13.1M | 14M | 13.39M | 11.74M |
| Stock-Based Compensation | 42K | 420K | 10.61M | 12.54M | 11.42M | 19.45M | 18.32M |
| Deferred Taxes | 0 | 0 | -8.9M | -505K | -52K | 0 | 0 |
| Other Non-Cash Items | 108K | 824K | 35.15M | -30K | 19.05M | -1.77M | -8.23M |
| Working Capital Changes | -89K | 1.01M | -3.15M | -1.54M | 1.52M | -368K | 423K |
| Change in Receivables | -102K | -1.37M | 230K | -148K | -666K | 2.24M | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 82K | 903K | 1.57M | -533K | -786K | 2.03M | 1.09M |
| Cash from Investing | -1.09M | -2.17M | -67.38M | -126.98M | 81.94M | -41.58M | -50.16M |
| Capital Expenditures | -1.1M | -2.18M | -38.05M | -16.18M | -860K | -404K | -1.11M |
| CapEx % of Revenue | 53.3% | 45.63% | 795.63% | 281.45% | 15.04% | 8.91% | 39.54% |
| Acquisitions | 0 | 0 | -28.13M | -8M | 0 | 0 | 1.31M |
| Investments | - | - | - | - | - | - | - |
| Other Investing | 9K | 10K | 0 | 783K | 254K | 939K | 0 |
| Cash from Financing | 12.71M | 70.97M | 336.19M | 5.24M | -4.48M | 82.53M | 105.95M |
| Debt Issued (Net) | 2.38M | 1.64M | 120.85M | 4.58M | -5.34M | -4.03M | -3.2M |
| Equity Issued (Net) | 10.33M | 69.33M | 215.34M | 656K | 862K | 86.56M | 109.14M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 5.58M▲ 0% | 57.83M▲ 935.5% | 208.22M▲ 260.0% | -203.08M▼ 197.5% | 12.82M▲ 106.3% | -31.45M▼ 345.2% | -37.14M▼ 18.1% |
| Free Cash Flow | -7.13M▲ 0% | -13.15M▼ 84.4% | -98.64M▼ 650.1% | -97.51M▲ 1.1% | -65.5M▲ 32.8% | -72.81M▼ 11.2% | -94.03M▼ 29.2% |
| FCF Margin % | -346.12% | -275.13% | -2062.84% | -1696.78% | -1145.44% | -1605.78% | -3358.29% |
| FCF Growth % | - | -84.45% | -650.09% | 1.15% | 32.83% | -11.16% | -29.15% |
| FCF per Share | -0.08 | -0.14 | -1.06 | -1.07 | -0.71 | -0.66 | -0.69 |
| FCF Conversion (FCF/Net Income) | 0.92x | 0.76x | 0.60x | 0.78x | 0.58x | 0.70x | 0.81x |
| Interest Paid | 202K | 508K | 652K | 895K | 970K | 561K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ABSI Key Ratios
Absci Corporation (ABSI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | -111.07% | -46.62% | -32.76% | -49.08% | -58.04% | -62.5% |
| Return on Invested Capital (ROIC) | - | - | -77.73% | -43.16% | -48.52% | -61.01% | -57.96% |
| Gross Margin | 100% | -139.5% | -832.37% | -925.02% | -731.88% | -1277.57% | -319.36% |
| Net Margin | -319.61% | -300.27% | -2111.25% | -1825.37% | -1933.65% | -2274.06% | -4113.68% |
| Debt / Equity | - | 0.22x | 0.05x | 0.08x | 0.09x | 0.06x | 0.03x |
| Interest Coverage | -23.57x | -21.64x | -21.66x | -109.83x | -92.75x | -190.24x | -596.74x |
| FCF Conversion | 0.92x | 0.76x | 0.60x | 0.78x | 0.58x | 0.70x | 0.81x |
| Revenue Growth | - | 132.04% | 0.04% | 20.18% | -0.5% | -20.71% | -38.24% |
ABSI SEC Filings & Documents
Absci Corporation (ABSI) SEC filings — annual & quarterly reports (10-K, 10-Q)
ABSI Frequently Asked Questions
Absci Corporation (ABSI) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Absci Corporation (ABSI) reported $2.8M in revenue for fiscal year 2025. This represents a 36% increase from $2.1M in 2019.
Absci Corporation (ABSI) saw revenue decline by 38.2% over the past year.
Absci Corporation (ABSI) reported a net loss of $115.2M for fiscal year 2025.
Dividend & Returns
Absci Corporation (ABSI) has a return on equity (ROE) of -62.5%. Negative ROE indicates the company is unprofitable.
Absci Corporation (ABSI) had negative free cash flow of $94.0M in fiscal year 2025, likely due to heavy capital investments.
Explore More ABSI
Absci Corporation (ABSI) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates